淋巴细胞白血病
解剖(医学)
白血病
生物
细胞
癌症研究
医学
遗传学
解剖
作者
Ilaria Iacobucci,Andy G.X. Zeng,Qingsong Gao,Laura García‐Prat,Pradyuamna Baviskar,Sayyam Shah,Alex Murison,Véronique Voisin,Michelle Chan‐Seng‐Yue,Cheng Cheng,Chunxu Qu,Colin Bailey,Matthew Lear,Matthew T. Witkowski,Xin Zhou,Airen Zaldívar Peraza,Karishma Gangwani,Anjali S. Advani,Selina M. Luger,Mark R. Litzow
标识
DOI:10.1101/2023.12.04.569954
摘要
ABSTRACT Sequencing of bulk tumor populations has improved genetic classification and risk assessment of B-ALL, but does not directly examine intratumor heterogeneity or infer leukemia cellular origins. We profiled 89 B-ALL samples by single-cell RNA-seq (scRNA-seq) and compared them to a reference map of normal human B-cell development established using both functional and molecular assays. Intra-sample heterogeneity was driven by cell cycle, metabolism, differentiation, and inflammation transcriptional programs. By inference of B lineage developmental state composition, nearly all samples possessed a high abundance of pro-B cells, with variation between samples mainly driven by sub-populations. However, ZNF384- r and DUX4- r B-ALL showed composition enrichment of hematopoietic stem cells, BCR::ABL1 and KMT2A -r ALL of Early Lymphoid progenitors, MEF2D -r and TCF3::PBX1 of Pre-B cells. Enrichment of Early Lymphoid progenitors correlated with high-risk clinical features. Understanding variation in transcriptional programs and developmental states of B-ALL by scRNA-seq refines existing clinical and genomic classifications and improves prediction of treatment outcome.
科研通智能强力驱动
Strongly Powered by AbleSci AI